V006-7723 Screening compound: 4-({2-[(3-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

V006-7723 Screening compound: 4-({2-[(3-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide
V006-7723 Screening compound: 4-({2-[(3-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-7723
4-({2-[(3-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-7723

Molecular Formula

C30H33ClN4O2 (C30 H33 ClN4 O2)

Compound Name

4-({2-[(3-chlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazol-1-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

IUPAC name

4-({2-[(3-chlorophenyl)methyl]-56-dimethyl-1H-13-benzodiazol-1-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]benzamide

SMILES

Cc(c(C)c1)cc2c1nc(Cc1cccc(Cl)c1)n2Cc(cc1)ccc1C(NCCN1CCOCC1)=O

InChI

InChI=1S/C30H33ClN4O2/c1-21-16-27-28(17-22(21)2)35(29(33-27)19-24-4-3-5-26(31)18-24)20-23-6-8-25(9-7-23)30(36)32-10-11-34-12-14-37-15-13-34/h3-9,16-18H,10-15,19-20H2,1-2H3,(H,32,36)

InChI Key

KUNWBYSNASHHJC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19782124

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517.07

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.442

Distribution Coefficient, logD

5.428

Water Solubility, LogSw

-5.92

Polar Surface Area

47.018

Acid Dissociation Constant (pKa)

12.39

Base Dissociation Constant (pKb)

5.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V006-7723 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with V006-7723 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-7723?
Check Price and Availability of V006-7723, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-7723 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-7723
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-7723
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-7723 available by request